MAZZEO, Anna
 Distribuzione geografica
Continente #
NA - Nord America 9.363
EU - Europa 7.013
AS - Asia 6.382
SA - Sud America 2.563
AF - Africa 202
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 13
Totale 25.552
Nazione #
US - Stati Uniti d'America 9.153
SG - Singapore 3.094
BR - Brasile 2.231
IE - Irlanda 1.734
CN - Cina 1.534
SE - Svezia 1.174
IT - Italia 902
HK - Hong Kong 764
RU - Federazione Russa 748
DE - Germania 684
FI - Finlandia 478
UA - Ucraina 404
VN - Vietnam 367
PL - Polonia 279
GB - Regno Unito 207
FR - Francia 161
IN - India 161
AR - Argentina 138
MX - Messico 83
CA - Canada 81
BD - Bangladesh 63
EC - Ecuador 58
TR - Turchia 57
ZA - Sudafrica 55
ID - Indonesia 47
BE - Belgio 45
IQ - Iraq 45
NL - Olanda 43
AT - Austria 37
MA - Marocco 37
CO - Colombia 33
UZ - Uzbekistan 32
CI - Costa d'Avorio 29
JP - Giappone 29
VE - Venezuela 27
ES - Italia 26
PK - Pakistan 25
KE - Kenya 23
PY - Paraguay 23
CL - Cile 21
AZ - Azerbaigian 18
TN - Tunisia 18
LT - Lituania 17
IL - Israele 16
PE - Perù 16
EU - Europa 15
CZ - Repubblica Ceca 14
KZ - Kazakistan 13
JO - Giordania 12
NP - Nepal 12
AL - Albania 11
AE - Emirati Arabi Uniti 10
DZ - Algeria 10
KR - Corea 10
AU - Australia 9
UY - Uruguay 9
DO - Repubblica Dominicana 8
EG - Egitto 8
LB - Libano 8
RS - Serbia 8
HN - Honduras 7
IR - Iran 7
JM - Giamaica 7
KG - Kirghizistan 7
PA - Panama 7
BO - Bolivia 6
PH - Filippine 6
SA - Arabia Saudita 6
SK - Slovacchia (Repubblica Slovacca) 6
GR - Grecia 5
GT - Guatemala 5
PS - Palestinian Territory 5
RO - Romania 5
AM - Armenia 4
BH - Bahrain 4
GA - Gabon 4
KW - Kuwait 4
LA - Repubblica Popolare Democratica del Laos 4
LK - Sri Lanka 4
SN - Senegal 4
BW - Botswana 3
CH - Svizzera 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
OM - Oman 3
SY - Repubblica araba siriana 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
CR - Costa Rica 2
DM - Dominica 2
HU - Ungheria 2
LU - Lussemburgo 2
LV - Lettonia 2
MD - Moldavia 2
NO - Norvegia 2
PR - Porto Rico 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
Totale 25.527
Città #
Dublin 1.729
Dallas 1.379
Singapore 1.154
Chandler 1.132
Ashburn 1.063
Jacksonville 862
Hong Kong 760
Nyköping 757
Beijing 671
Messina 335
Princeton 304
Munich 292
Medford 275
Warsaw 273
Los Angeles 246
Cambridge 233
The Dalles 232
Moscow 225
Des Moines 215
Ann Arbor 182
Dearborn 180
São Paulo 158
Helsinki 149
Buffalo 145
Ho Chi Minh City 136
New York 134
Boardman 100
Wilmington 79
Turku 75
Tianjin 71
Redondo Beach 69
Rio de Janeiro 69
San Mateo 67
Jinan 65
Shenyang 61
Belo Horizonte 59
Hanoi 56
Bremen 52
Pune 45
Woodbridge 45
Hyderabad 43
Brasília 42
Lancaster 41
Houston 40
Nanjing 36
Curitiba 35
Santa Clara 35
Brooklyn 33
Council Bluffs 33
Ningbo 33
Seattle 33
Porto Alegre 32
Hebei 31
Nuremberg 31
Zhengzhou 31
Brussels 30
Tashkent 30
Abidjan 29
Hangzhou 29
Montreal 28
Johannesburg 27
London 27
Haikou 26
San Francisco 26
Chennai 25
Guangzhou 25
Salvador 25
Tokyo 25
Boston 24
Chicago 24
Mexico City 24
Campinas 23
Denver 23
Taizhou 23
Frankfurt am Main 22
Guayaquil 22
Lappeenranta 22
Nairobi 22
Orem 22
Rome 22
Catania 21
Norwalk 21
Ribeirão Preto 21
Guarulhos 20
Jakarta 20
Mumbai 19
Quito 19
Vienna 19
Baku 18
Da Nang 17
Palermo 17
Redwood City 17
Stockholm 17
Washington 17
Amsterdam 16
Atlanta 16
Baghdad 16
Dhaka 16
Dong Ket 16
Phoenix 16
Totale 15.647
Nome #
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 306
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 256
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR) 242
Value of 99mTc-DPD scintigraphy as early diagnostic modality in familial amyloidotic polyneuropathy. 229
Clinical and pathological features of focal myositis 227
Etanercept for psoriasis and psoriatic arthritis in a patient with Charcot-Marie-Tooth disease 220
Responsiveness of clinical outcome measures in Charcot-Marie-Tooth disease 218
A CMT1A PATIENT WITH PAINFUL AND DISABLING SYMPTOMS: FAST RECOVERY AFTER IVIG TREATMENT. 195
Diagnostic utility of Sudoscan for detecting Bortezomib-induced painful neuropathy 184
HATTR italian registry: preliminary data from the collaborative network of telethon GUP 15010 study 177
2D Feature Strain Echocardiography in patients with transthyretin familial amyloid plyneuropathy and diffuse cardiac 99mTc-DPD accumulation 169
A Nouvel serum MicroRNA signature to screen ATTR 169
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 158
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 157
A family with autosomal dominant mutilating neuropathy not linked to either Charcot-Marie-Tooth disease type 2B (CMT2B) or hereditary sensory neuropathy type I (HSN I) loci 156
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 151
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol 149
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 146
"Dropped- head" syndrome due to isolated myositis of neck extensor muscles: MRI findings 142
A novel mutation in KIF5A gene causing hereditary spastic paraplegia with axonal neuropathy. 139
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy 138
Comparison Between 99mTc-Diphosphonate Imaging and MRI With Late Gadolinium Enhancement in Evaluating Cardiac Involvement in Patients With Transthyretin Familial Amyloid Polyneuropathy 133
Behaviour of vinculin and talin in perineurial cells in healthy subjects and in subjects affected by diabteic neuropathy 128
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis. 127
Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report 125
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies 123
ANT1 is reduced in sporadic inclusion body myositis. 123
ATTRv amyloidosis Italian Registry: clinical and epidemiological data 123
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study 122
Charcot-Marie-Tooth 2F: phenotypic presentation of the Arg136Leu HSP27 mutation in a multigenerational family 121
Amyloid myopathy presenting with rhabdomyolysis: Evidence of complement activation 120
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 119
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study. 118
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 118
Activation of nuclear factor-kappa B in inflammatory myopathies and Duchenne muscular dystrophy 117
Cardiac 99mTc-DPD uptake in subjects with Glu89Gln transthyretin gene mutation: is it the earliest sign of disease development? 117
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study 116
Acquired idiopathic generalized anhidrosis: a case report 115
NfL as a biomarker in ATTRv amyloidosis: potential and limitations 114
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study 114
Coinvolgimento Cardiaco in Pazienti con Polineuropatia Amiloidotica Familiare: Dimostrazione Precoce con Cardio-Rm 114
Activation of nuclear factor-κB in inflammatory myopathies and Duchenne muscular dystrophy 112
Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene 112
Sport activity in Charcot-Marie-Tooth disease: A case study of a Paralympic swimmer 111
Are novel outcome measures for Charcot–Marie–Tooth disease sensitive to change? The 6-minute walk test and StepWatch™ Activity Monitor in a 12-month longitudinal study 109
Prevalence and diagnostic value of extra-left ventricle echocardiographic findings in transthyretin-related cardiac amyloidosis 109
Nerve conduction velocity in CMT1A: what else can we tell? 108
Acquired idiopathic generalized anhidrosis: a case report 107
Myopathy as the persistently isolated symptomatology of primary autoimmune hypothyroidism 107
A novel Cx32 mutation with unusual phenotype. 107
Correlation between semiquantitative analysis of 99mTc-DPD scintigraphy and clinical scores in patients with familial amyloidotic polyneuropathy 105
A NOVEL MUTATION IN KIF5A GENE CAUSING HEREDITARY SPASTIC PARAPLEGIA WITH AXONAL NEUROPATHY; 105
Is overwork weakness relevant in Charcot-Marie-Tooth disease? 105
A novel Cx32 mutation with unusual phenotype 104
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life 104
Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry 104
Amyloid myopathy presenting with rhabdomyolysis 103
A novel CX32 mutation with unusual phenotype 103
Cardiac Involvement in Patients with Family Amyloid Polyneuropathy: Early Demostration with Cardiac Magnetic Resonance 103
Activation and localization of transcription factor NF-KB in peripheral neuropathies of different origin. 103
TRANSTHYRETIN AMYLOIDOSIS IN SOUTHERN ITALY POPULATION: DESCRIPTION OF A COHORT OF PATIENTS WITH PHE64LEU MUTATION AND LATE ONSET 102
Cardiac involvement in transthyretin familial amyloid polyneuropathy - comparison between 99mTc-DPD SPECT and magnetic resonance imaging 102
Amyloid myopathy presenting with rhabdomyolysis: evidence of complement activation. 101
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies 101
Mid-basal left ventricular longitudinal dysfunction as a prognostic marker in mutated transthyretin-related cardiac amyloidosis 101
Charcot-Marie-Tooth type X: unusual phenotype of a novel CX32 mutation 100
LOCALIZATION OF VINCULIN AND TALIN AT PERINEURIAL CELLS OF HUMAN SURAL NERVE 100
Bilateral symmetrical peroneal neuropathy: rapid recovery after IVIG 99
Quantitative comparison between amyloid deposition detected by 99mTC-diphosphonate imaging and myocardial deformation evaluated by strain echocardiography in transthyretin-related cardiac amyloidosis 99
Phenotypic variability of TTR Val122Ile mutation: a Caucasian patient with axonal neuropathy and normal heart 99
Parenteral nutrition improves nutritional status, autonomic symptoms and qol in patients with TTR-FAP 99
Multifocal motor neuropathy and asymptomatic Hashimoto's thyroiditis: first report of an association 98
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial 98
Amyloid myopathy presenting with rhabdomyolisis: evidence of complement activation. 98
Usefulness of Combining Electrocardiographic and Echocardiographic Findings and Brain Natriuretic Peptide in Early Detection of Cardiac Amyloidosis in Subjects With Transthyretin Gene Mutation 98
Atypical rat cerebellar immunoreactivity in a patient with familial amyloid polyneuropathy. 97
Atypical rat cerebellar immunoreactivity in a patient with familial amyloid polyneuropathy. 97
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study. 97
Early Impairment of Right Ventricular Morphology and Function in Transthyretin-Related Cardiac Amyloidosis 97
Autoimmune polyglandular disease (APECED) and mutineuropathy: a case report 96
Facial onset sensory motor neuronopathy: not always a slowly progressive disorder. 96
Bilateral symmetrical peroneal neuropathy: rapid recovery after IVIG. 96
Serial scanning with 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid (99mTc-DPD) for early detection of cardiac amyloid deposition and prediction of clinical worsening in subjects carrying a transthyretin gene mutation 96
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis 95
Espressione di ANT1 e attivazione della via RAGE-NF-kB nella miosite a corpi inclusi. 94
Atrial function in cardiac amyloidosis: a 2d-strain echocardiography and cardiac MRI study 94
Rasch-Transformed Total Neuropathy Score clinical version (RT-TNSc©) in patients with chemotherapy-induced peripheral neuropathy 94
VEGF overexpression via adeno-associated virus gene transfer promotes skeletal muscle regeneration and enhances muscle function in mdx mice 92
MRI of cardiac involvement in transthyretin familial amyloid polyneuropathy 92
MRI findings, patterns of disease distribution, and muscle fat fraction calculation in five patients with Charcot-Marie-Tooth type 2 F disease. 92
A novel CX32 mutation with unusual phenotype 92
EXPRESSION OF CYTOSKELETON PROTEINS IN CENTRAL CORE DISEASE 91
Dp116, talin, vinculin and vimentin immunoreactivities following nerve transection 91
AUTONOMIC DYSFUNCTION AND HEART INVOLVEMENT IN TRANSTHYRETIN FAMILIAL AMYLOIDOTIC POLYNEUROPATHY 91
TRPV4 related scapuloperoneal spinal muscular atrophy: Report of an Italian family and review of the literature 91
A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy 91
Late-onset mitochondrial neuromyopathy: an age-related phenomenon ? 90
Amyloid myopathy presenting with rhabdomyolysis. 90
CMT subtypes in a cohort of italian patients enrolled at Messina neuromuscular centre since 1994 to 2014. 90
Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center 90
Totale 12.183
Categoria #
all - tutte 101.787
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.787


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021797 0 0 0 0 0 159 65 123 52 201 130 67
2021/20221.696 26 189 33 85 100 15 136 87 41 95 204 685
2022/20234.574 394 393 223 314 320 420 47 252 2.051 22 105 33
2023/20241.112 82 188 92 74 98 257 26 69 5 73 13 135
2024/20256.868 130 61 96 371 289 319 308 1.316 1.567 339 834 1.238
2025/20267.191 825 1.286 1.534 1.340 1.402 804 0 0 0 0 0 0
Totale 26.148